Decades of clinical psychological science have produced many evidence-based interventions that are now undergoing dissemination and implementation (DI), but with little guidance from a DI science that is just now taking shape. Charting a future for DI science and practice, and their complex relationship, will be complicated by significant challenges-the implementation cliff(treatment benefit drops when tested practices are taken to scale), low relevance of most clinical research to actual practice, and differing timetables and goals for DI practice versus research. To address the challenges, and prepare the next generation of psychologists, we propose: making intervention research look more like practice, solving the "too many EBPs" problem, addressing mismatches between interventions and their users, broadening our range of intervention delivery systems, sharpening outcome monitoring and feedback, incentivizing high-risk/high-gain innovations, designing new professional tracks for DI science, and synchronizing and linking the often-insular practice and science of DI.Keywords: dissemination, implementation, evidence-based practice Science and Practice of Dissemination and Implementation 3 An emerging challenge in clinical psychological science is the tension between rigorous testing of interventions-an ongoing task that is never really finished-and deploying those interventions within clinical practice settings. Moving too quickly from science to practice can make us marketers with products not yet ready for prime time. Moving too slowly can mean lost opportunities to take our work to scale and improve clinical care for those who need it. In this paper we focus on the tension between science and practice-whether the two are a cute couple or strange bedfellows-in the development and diffusion of interventions, and implications of the science-practice relationship for clinical training.
Welcome to COI World.This science-practice tension is highlighted by the annual conflict-of-interest (COI) reports that are now routine for faculty in North American universities. In decades past, intervention science and practice were indeed a cute couple (with rather socialist leanings) in which scientists developed and tested treatment protocols and shared these openly for use by practitioners who wanted them. That openness has now given way to a more capitalist model in which these products are "IP," owned and marketed, often for income beyond the wildest dreams of prior generations in our field. Under these circumstances, a fair study with adverse findings regarding a treatment program can have major consequences-including loss of employment for those in the business of spreading the treatment, loss of income for the IP-holder and partners, and loss of image in the marketplace with concomitant loss of market share. The resulting pressure on scientists who develop marketable products can be significant, and the potential for conflict of interest is real-hence the need for COI reports. While this situation is not new ...